Magnetic resonance imaging proton density fat fraction as an imaging-based biomarker of treatment response in patients with nonalcoholic steatohepatitis.
Jonathan G StineRohit LoombaPublished in: Clinical liver disease (2022)
Content available: Author Interview and Audio Recording.